Zoetis Inc. Files 2024 10-K Annual Report
Ticker: ZTS · Form: 10-K · Filed: 2025-02-13T00:00:00.000Z
Sentiment: neutral
Topics: annual-report, financials, pharmaceuticals
TL;DR
Zoetis dropped its 2024 10-K. Full financials for the year ending Dec 31, 2024 are out.
AI Summary
Zoetis Inc. filed its 2024 10-K on February 13, 2025, reporting on its fiscal year ending December 31, 2024. The company, headquartered in Parsippany, NJ, operates in the pharmaceutical preparations sector. The filing covers financial performance and business operations for the fiscal year 2024, with comparative data from 2023 and 2022.
Why It Matters
This filing provides investors and stakeholders with a comprehensive overview of Zoetis's financial health, strategic initiatives, and risk factors for the 2024 fiscal year, crucial for investment decisions.
Risk Assessment
Risk Level: low — This is a standard annual report filing for a publicly traded company, providing routine financial and operational disclosures.
Key Numbers
- 2024 — Fiscal Year (Reporting period for the 10-K)
- 2023 — Prior Fiscal Year (Comparative financial data)
- 2022 — Prior Fiscal Year (Comparative financial data)
Key Players & Entities
- Zoetis Inc. (company) — Filer of the 10-K
- Parsippany, NJ (location) — Company headquarters
- 2024-12-31 (date) — Fiscal year end
- 2025-02-13 (date) — Filing date
FAQ
What is the primary business of Zoetis Inc. as indicated in the filing?
Zoetis Inc. is primarily involved in Pharmaceutical Preparations, as indicated by its SIC code [2834].
When was the 10-K filing for Zoetis Inc. submitted to the SEC?
The 10-K filing was submitted on February 13, 2025.
What is the fiscal year end date for Zoetis Inc. reported in this 10-K?
The fiscal year end date is December 31, 2024.
Where is Zoetis Inc. headquartered?
Zoetis Inc. is headquartered at 10 Sylvan Way, Parsippany, NJ 07054.
What SEC Act and File Number are associated with this filing?
This filing is made under the 1934 Act with SEC File Number 001-35797.
From the Filing
0001555280-25-000102.txt : 20250213 0001555280-25-000102.hdr.sgml : 20250213 20250213145125 ACCESSION NUMBER: 0001555280-25-000102 CONFORMED SUBMISSION TYPE: 10-K PUBLIC DOCUMENT COUNT: 130 CONFORMED PERIOD OF REPORT: 20241231 FILED AS OF DATE: 20250213 DATE AS OF CHANGE: 20250213 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Zoetis Inc. CENTRAL INDEX KEY: 0001555280 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 460696167 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-35797 FILM NUMBER: 25619555 BUSINESS ADDRESS: STREET 1: 10 SYLVAN WAY CITY: PARSIPPANY STATE: NJ ZIP: 07054 BUSINESS PHONE: 973-822-7000 MAIL ADDRESS: STREET 1: 10 SYLVAN WAY CITY: PARSIPPANY STATE: NJ ZIP: 07054 10-K 1 zts-20241231.htm 10-K zts-20241231 false 2024 FY 0001555280 http://fasb.org/us-gaap/2024#OtherAssetsNoncurrent http://fasb.org/us-gaap/2024#OtherAssetsNoncurrent http://fasb.org/us-gaap/2024#OtherLiabilitiesCurrent http://fasb.org/us-gaap/2024#OtherLiabilitiesCurrent http://fasb.org/us-gaap/2024#OtherLiabilitiesCurrent http://fasb.org/us-gaap/2024#OtherLiabilitiesCurrent http://fasb.org/us-gaap/2024#OtherLiabilitiesNoncurrent http://fasb.org/us-gaap/2024#OtherLiabilitiesNoncurrent http://fasb.org/us-gaap/2024#OtherLiabilitiesNoncurrent http://fasb.org/us-gaap/2024#OtherLiabilitiesNoncurrent iso4217:USD xbrli:shares iso4217:USD xbrli:shares zts:geographicRegion zts:country zts:specie zts:product_category xbrli:pure iso4217:EUR iso4217:DKK iso4217:CHF zts:defendant zts:segment 0001555280 2024-01-01 2024-12-31 0001555280 2024-06-30 0001555280 2025-02-07 0001555280 2023-01-01 2023-12-31 0001555280 2022-01-01 2022-12-31 0001555280 us-gaap:CashFlowHedgingMember 2024-01-01 2024-12-31 0001555280 us-gaap:CashFlowHedgingMember 2023-01-01 2023-12-31 0001555280 us-gaap:CashFlowHedgingMember 2022-01-01 2022-12-31 0001555280 us-gaap:NetInvestmentHedgingMember 2024-01-01 2024-12-31 0001555280 us-gaap:NetInvestmentHedgingMember 2023-01-01 2023-12-31 0001555280 us-gaap:NetInvestmentHedgingMember 2022-01-01 2022-12-31 0001555280 2024-12-31 0001555280 2023-12-31 0001555280 2021-12-31 0001555280 us-gaap:CommonStockMember 2021-12-31 0001555280 us-gaap:TreasuryStockCommonMember 2021-12-31 0001555280 us-gaap:AdditionalPaidInCapitalMember 2021-12-31 0001555280 us-gaap:RetainedEarningsMember 2021-12-31 0001555280 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-12-31 0001555280 us-gaap:NoncontrollingInterestMember 2021-12-31 0001555280 us-gaap:RetainedEarningsMember 2022-01-01 2022-12-31 0001555280 us-gaap:NoncontrollingInterestMember 2022-01-01 2022-12-31 0001555280 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-01-01 2022-12-31 0001555280 us-gaap:TreasuryStockCommonMember 2022-01-01 2022-12-31 0001555280 us-gaap:AdditionalPaidInCapitalMember 2022-01-01 2022-12-31 0001555280 zts:ShareRepurchaseProgramMember 2022-01-01 2022-12-31 0001555280 2022-12-31 0001555280 us-gaap:CommonStockMember 2022-12-31 0001555280 us-gaap:TreasuryStockCommonMember 2022-12-31 0001555280 us-gaap:AdditionalPaidInCapitalMember 2022-12-31 0001555280 us-gaap:RetainedEarningsMember 2022-12-31 0001555280 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-12-31 0001555280 us-gaap:NoncontrollingInterestMember 2022-12-31 0001555280 us-gaap:RetainedEarningsMember 2023-01-01 2023-12-31 0001555280 us-gaap:NoncontrollingInterestMember 2023-01-01 2023-12-31 0001555280 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-01-01 2023-12-31 0001555280 us-gaap:TreasuryStockCommonMember 2023-01-01 2023-12-31 0001555280 us-gaap:AdditionalPaidInCapitalMember 2023-01-01 2023-12-31 0001555280 zts:ShareRepurchaseProgramMember 2023-01-01 2023-12-31 0001555280 us-gaap:CommonStockMember 2023-12-31 0001555280 us-gaap:TreasuryStockCommonMember 2023-12-31 0001555280 us-gaap:AdditionalPaidInCapitalMember 2023-12-31 0001555280 us-gaap:RetainedEarningsMember 2023-12-31 0001555280 us-gaap:Accumu